BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3435928)

  • 21. [Lead and delta-aminolevulinic acid in urine: quality control].
    Grisler R; Gobbi A; Colombo G; Colombo R; Valla C
    Med Lav; 1974; 65(5-6):202-5. PubMed ID: 4456167
    [No Abstract]   [Full Text] [Related]  

  • 22. [Correlation of urinary hemoglobin and delta-aminolevulinic acid in adults males exposed to lead (author's transl)].
    Molina Ballesteros G; Zúñiga-Charles MA; Sánchez-Anzaldo FJ
    Rev Invest Clin; 1979; 31(3):245-9. PubMed ID: 523859
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biochemical study of various occupational groups exposed to lead].
    Kutter D; Machoud M
    Bull Soc Sci Med Grand Duche Luxemb; 1978; 115(1):35-41. PubMed ID: 699239
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adjustment of urinary delta-aminolevulinic acid concentrations in workers exposed to lead and heat. Adjustments of specific gravity to 1.020 and urinary volume coefficients].
    Hirano H; Ohmichi M; Hanazawa K; Ishikawa K; Hirashima N; Usui S; Yoshio K
    Sangyo Igaku; 1984 May; 26(3):205-11. PubMed ID: 6521057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative determination of urinary delta-aminolevulinic acid as an index of lead exposure by high-performance liquid chromatography.
    Ogata M; Taguchi T
    Ind Health; 1986; 24(4):259-64. PubMed ID: 3818368
    [No Abstract]   [Full Text] [Related]  

  • 26. [A simple photometric test for the routine determination of delta-aminolaevulinic acid in urine for the control of lead exposure].
    Hoeflmayr J; Fried R; Wildgruber R
    Dtsch Med Wochenschr; 1975 Jan; 100(5):187-91. PubMed ID: 1053992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urine concentration of delta ALA in children: an indicator of lead contamination in Santiago (author's transl)].
    Cisternas R; Sáez M
    Rev Chil Pediatr; 1980; 51(1):13-8. PubMed ID: 7422942
    [No Abstract]   [Full Text] [Related]  

  • 28. [Renal delta-aminolevulinic acid excretion in persons not exposed to lead].
    Massmann W
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie; 1982 Jun; 32(6):210-2. PubMed ID: 7113496
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary delta-aminolevulinic acid as a biological indicator throughout penicillamine therapy in lead intoxication.
    Molina-Ballesteros G; Zuñiga-Charles MA; Sanchez-Anzaldo FJ; Gonzalez-Ramirez JD
    Arch Environ Health; 1978; 33(6):308-13. PubMed ID: 736614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new HPLC fluorimetric method to monitor urinary delta-aminolevulinic acid (ALA-U) levels in workers exposed to lead.
    Okayama A; Ogawa Y; Miyajima K; Hirata M; Yoshida T; Tabuchi T; Sugimoto K; Morimoto K
    Int Arch Occup Environ Health; 1989; 61(5):297-302. PubMed ID: 2707866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of urinary delta-aminolevulinic acid using a descrete automatized analyzer].
    Cavalleri A; Bianco L; Biscaldi GP
    Med Lav; 1976; 67(2):145-51. PubMed ID: 1021707
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of urea on the simple determination of delta-aminolevulinic acid in urine.
    Tomokuni K; Hirai Y
    Ind Health; 1985; 23(4):295-7. PubMed ID: 3833861
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluorimetric determination of urinary delta-aminolevulinic acid by high-performance liquid chromatography and post-column derivatization.
    Okayama A
    J Chromatogr; 1988 Apr; 426(2):365-9. PubMed ID: 3392148
    [No Abstract]   [Full Text] [Related]  

  • 34. [The value of determining delta-aminolevulinic acid in urine (method II, East German occupational monitoring) as a screening procedure for the assessment of internal residues in occupational exposure to lead].
    Pannier R; Behning I; Praefke K; Hübner G
    Z Gesamte Hyg; 1989 Jan; 35(1):22-3. PubMed ID: 2922940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species difference of urinary excretion of delta-aminolevulinic acid and coproporphyrin in mice and rats exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y
    Toxicol Lett; 1988 Jun; 41(3):255-9. PubMed ID: 3376152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a new specific analysis of urinary delta-aminolevulinic acid in man.
    Witting U; Binding N; Müller G
    Int Arch Occup Environ Health; 1987; 59(4):375-83. PubMed ID: 3610337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary delta amino levulinic acid (ALA) in the cow, dog and cat.
    McSherry BJ; Willoughby RA; Thomson RG
    Can J Comp Med; 1971 Apr; 35(2):136-40. PubMed ID: 4253462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creatinine and specific gravity adjustment of ALA in urinary spot samples: is there any need?
    Dell'Orto A; Berlin A; Toffoletto F; Losito B; Alessio L
    Am Ind Hyg Assoc J; 1987 May; 48(5):A331-2. PubMed ID: 3591657
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors affecting determination of delta-aminolevulinate by use of Ehrlich's reagent.
    Tomokuni K; Hirai Y
    Clin Chem; 1986 Jan; 32(1 Pt 1):192-3. PubMed ID: 3940706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine delta-aminolevulinic acid and erythropoietic activity in human lead intoxication.
    Canberk A; Sehirli I; Canberk Y; Koyuncuoŏglu H
    Toxicol Appl Pharmacol; 1978 May; 44(2):257-61. PubMed ID: 675700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.